Citations (61)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (1)
Aloke V Finn, Marc Vorpahl, Elena Ladich & Renu Virmani. (2010) Future directions in stenting. Expert Review of Cardiovascular Therapy 8:1, pages 1-6.
Read now
Read now
Articles from other publishers (60)
J. Ribamar CostaJr.Jr., Ridhima Goel, Rafael Alexandre Meneguz‐Moreno & Alexandre A.C. Abizaid. 2022. Interventional Cardiology. Interventional Cardiology
384
398
.
Michele Marino, Giuseppe Vairo & Peter Wriggers. (2021) Mechano-chemo-biological Computational Models for Arteries in Health, Disease and Healing: From Tissue Remodelling to Drug-eluting Devices. Current Pharmaceutical Design 27:16, pages 1904-1917.
Crossref
Crossref
Alper Öner, Caroline Moerke, Anne Wolff, Sabine Kischkel, Wolfram Schmidt, Niels Grabow & Hüseyin Ince. (2020) A preclinical animal model for evaluating the sealing capacity of covered stent grafts in acute vessel perforation. European Journal of Medical Research 25:1.
Crossref
Crossref
James M. Anderson, Frederick J. Schoen & Nicholas P. Ziats. 2020. Biomaterials Science. Biomaterials Science
869
877
.
Anne Seidlitz. 2019. In Vitro Drug Release Testing of Special Dosage Forms. In Vitro Drug Release Testing of Special Dosage Forms
87
117
.
Nicole Kirchhof. (2019) What Is “Preclinical Device Pathology”: An Introduction of the Unfamiliar. Toxicologic Pathology 47:3, pages 205-212.
Crossref
Crossref
Jiro Aoki, Ken Kozuma, Masaki Awata, Mamoru Nanasato, Nobuo Shiode, Kengo Tanabe, Junichi Yamaguchi, Hajime Kusano, Hong Nie & Takeshi Kimura. (2018) Five-year clinical outcomes of everolimus-eluting stents from the post marketing study of CoCr-EES (XIENCE V/PROMUS) in Japan. Cardiovascular Intervention and Therapeutics 34:1, pages 40-46.
Crossref
Crossref
Shintaro Nakamura, Atsushi Sakaoka, Eri Ikuno, Ryouhei Asou, Daiki Shimizu & Hitomi Hagiwara. (2019) Optimal implantation site of transponders for identification of experimental swine. Experimental Animals 68:1, pages 13-23.
Crossref
Crossref
Shayne C. GadDavid W. Hobson. 2019. Integrated Safety and Risk Assessment for Medical Devices and Combination Products. Integrated Safety and Risk Assessment for Medical Devices and Combination Products
401
428
.
Atsushi Sakamoto, Hiroyuki Jinnouchi, Sho Torii, Renu Virmani & Aloke Finn. (2018) Understanding the Impact of Stent and Scaffold Material and Strut Design on Coronary Artery Thrombosis from the Basic and Clinical Points of View. Bioengineering 5:3, pages 71.
Crossref
Crossref
Marc Silvestri, Manjunath Cholenahally Nanjappa, Rame Gowda Raghu & Rajagopal Jambunathan. (2018) Interim Results of the Basket of Real-World Randomised Clinical PRISM Trials for M’Sure-S, a Next-Generation Sirolimus-Eluting Stent, Versus Eliminator, an Everolimus-Eluting Stent. European Medical Journal, pages 30-38.
Crossref
Crossref
Takao Sato, Yuji Taya, Naomasa Suzuki, Sho Yuasa, Shohei Kishi, Tomoyasu Koshikawa, Koichi Fuse, Satoshi Fujita, Yoshio Ikeda, Hitoshi Kitazawa, Minoru Takahashi, Masaaki Okabe & Yoshifusa Aizawa. (2018) The comparison of early healing 1-month after PCI among CoCr-everolimus-eluting stent (EES), biodegradable polymer (BP)-EES and BP-sirolimus-eluting stent: Insights from OFDI and coronary angioscopy. IJC Heart & Vasculature 20, pages 40-45.
Crossref
Crossref
Setareh Borhani, Shadi Hassanajili, Seyed Hossein Ahmadi Tafti & Shahram Rabbani. (2018) Cardiovascular stents: overview, evolution, and next generation. Progress in Biomaterials 7:3, pages 175-205.
Crossref
Crossref
Takao Sato, Katsuharu Hatada, Syohei Kishi, Koichi Fuse, Satoshi Fujita, Yoshio Ikeda, Minoru Takahashi, Taku Matsubara, Masaaki Okabe & Yoshifusa Aizawa. (2017) Comparison of clinical outcomes of coronary artery stent implantation in patients with end‐stage chronic kidney disease including hemodialysis for three everolimus eluting (EES) stent designs: Bioresorbable polymer‐EES, platinum chromium‐EES, and cobalt chrome‐EES. Journal of Interventional Cardiology 31:2, pages 170-176.
Crossref
Crossref
Shady Farah. (2018) Protective Layer Development for Enhancing Stability and Drug-Delivery Capabilities of DES Surface-Crystallized Coatings. ACS Applied Materials & Interfaces 10:10, pages 9010-9022.
Crossref
Crossref
Shady Farah & Abraham J. Domb. (2018) Crystalline paclitaxel coated DES with bioactive protective layer development. Journal of Controlled Release 271, pages 107-117.
Crossref
Crossref
Gaku Nakazawa & Tooru Nakamura-Hirota. (2018) Evaluation of safety and efficacy of biodegradable polymer-based sirolimus-eluting stent in a porcine coronary artery model. Journal of Biorheology 32:2, pages 71-77.
Crossref
Crossref
Minjee Kang, Byeongdu Lee & Cecilia Leal. (2017) Three-Dimensional Microphase Separation and Synergistic Permeability in Stacked Lipid–Polymer Hybrid Membranes. Chemistry of Materials 29:21, pages 9120-9132.
Crossref
Crossref
Jitendra S. Kanshana, Vivek Khanna, Vishal Singh, Manish Jain, Ankita Misra, Sachin Kumar, Mariya Farooqui, Manoj K. Barthwal & Madhu Dikshit. (2017) Progression and Characterization of the Accelerated Atherosclerosis in Iliac Artery of New Zealand White Rabbits: Effect of Simvastatin. Journal of Cardiovascular Pharmacology 69:5, pages 314-325.
Crossref
Crossref
J. Ribamar CostaJr.Jr., Daniel Chamié, Alexandre A. C. Abizaid, Expedito Ribeiro, George C. Meireles, Maurício Prudente, Carlos A. Campos, Juliana P. Castro, Ricardo Costa & Pedro A. Lemos. (2016) Intravascular imaging comparison of two metallic limus-eluting stents abluminally coated with biodegradable polymers: IVUS and OCT results of the DESTINY trial. The International Journal of Cardiovascular Imaging 33:2, pages 161-168.
Crossref
Crossref
J. Ribamar CostaJr.Jr., Adriano Caixeta & Alexandre A.C. Abizaid. 2017. Interventional Cardiology. Interventional Cardiology
368
376
.
Kleanthis Theodoropoulos, Marco G. Mennuni, George D. Dangas, Omar A. Meelu, Sameer Bansilal, Usman Baber, Samantha Sartori, Jason C. Kovacic, Pedro R. Moreno, Samin K. Sharma, Roxana Mehran & Annapoorna S. Kini. (2016) Resistant in-stent restenosis in the drug eluting stent era. Catheterization and Cardiovascular Interventions 88:5, pages 777-785.
Crossref
Crossref
Rajendra Kumar Jain, Padmanabha Chakravarthi, Rajan Shetty, Padmakumar Ramchandra, Raghava Sarma Polavarapu, Gurupreet Singh Wander, Bishav Mohan, Darshan Navinchandra Banker, Aniruddha Dharmadhikari, Shyam Sundar Bansal, Neeraj Jain, Dharmesh Solanki, Jagdish Dhakaan, Ved Prakash Sharma, Padhinhare P. Mohanan, Parayaru Kottayal Ashokan, Bagur Venkat Manjunath, Narendra Hiregoudar, Chandrashekar Patil & Narasimha Balakrishnan. (2016) One-year outcomes of a BioMime™ Sirolimus-Eluting Coronary Stent System with a biodegradable polymer in all-comers coronary artery disease patients: The meriT-3 study. Indian Heart Journal 68:5, pages 599-603.
Crossref
Crossref
Lei Gao, Stephen Lee, Chong-Jin Kim, Yoshiyasu Minami, Daniel S. Ong, Tsunenari Soeda, Harry Lowe, So-Yeon Choi, Amir Lerman, Jay Lee, Hang Lee, Shiro Uemura, Bo Yu & Ik-Kyung Jang. (2016) Incidence and Morphological Predictors of Intrastent Coronary Thrombus After Drug-Eluting Stent Implantation (from a Multicenter Registry). The American Journal of Cardiology 117:3, pages 369-375.
Crossref
Crossref
Mahender N. Avula & David W. Grainger. 2015. Drug-Device Combinations For Chronic Diseases. Drug-Device Combinations For Chronic Diseases
1
38
.
Michele d’Errico, Paolo Sammarco & Giuseppe Vairo. (2015) Analytical modeling of drug dynamics induced by eluting stents in the coronary multi-layered curved domain. Mathematical Biosciences 267, pages 79-96.
Crossref
Crossref
Anne Seidlitz, Monika Wentzlaff & Werner Weitschies. (2015) Controlling drug delivery from coronary stents: are we aiming for the right targets?. Therapeutic Delivery 6:6, pages 705-720.
Crossref
Crossref
Tingzhang Hu, Jiali Yang, Kun Cui, Qiong Rao, Tieying Yin, Lili Tan, Yuan Zhang, Zhenggong Li & Guixue Wang. (2015) Controlled Slow-Release Drug-Eluting Stents for the Prevention of Coronary Restenosis: Recent Progress and Future Prospects. ACS Applied Materials & Interfaces 7:22, pages 11695-11712.
Crossref
Crossref
Marc Vorpahl, Masataka Nakano, Laura E. L. Perkins, Fumiyuki Otsuka, Russell Jones, Eduardo Acampado, Jennifer P. Lane, Richard Rapoza, Frank D. Kolodgie & Renu Virmani. (2014) Vascular healing and integration of a fully bioresorbable everolimus-eluting scaffold in a rabbit iliac arterial model. EuroIntervention 10:7, pages 833-841.
Crossref
Crossref
Gaku Nakazawa, Toshiro Shinke, Takeshi Ijichi, Daisuke Matsumoto, Hiromasa Otake, Sho Torii, Noritoshi Hiranuma, Tsuyoshi Ohsue, Fumiyuki Otsuka, Junya Shite, Ken-ichi Hirata & Yuji Ikari. (2014) Comparison of vascular response between durable and biodegradable polymer-based drug-eluting stents in a porcine coronary artery model. EuroIntervention 10:6, pages 717-723.
Crossref
Crossref
Giampaolo Niccoli, Gregory A. Sgueglia, Rocco A. Montone, Marco Roberto, Adrian P. Banning & Filippo Crea. (2014) Evolving management of patients treated by drug-eluting stent: Prevention of late events. Cardiovascular Revascularization Medicine 15:2, pages 100-108.
Crossref
Crossref
Fumiyuki OtsukaMarc VorpahlMasataka NakanoJason FoerstJohn B. NewellKenichi SakakuraRobert KutysElena LadichAloke V. FinnFrank D. KolodgieRenu Virmani. (2014) Pathology of Second-Generation Everolimus-Eluting Stents Versus First-Generation Sirolimus- and Paclitaxel-Eluting Stents in Humans. Circulation 129:2, pages 211-223.
Crossref
Crossref
Takao Maeda, Takayuki Okamura, Jutaro Yamada, Tomoko Nao, Hiroki Tateishi, Masayuki Yoshimura, Takamasa Oda, Kohzoh Shiraishi, Tadamitsu Nakashima, Takeshi Nakamura, Toshiro Miura & Masafumi Yano. (2013) Serial three-dimensional optical coherence tomography assessment of strut coverage and intraluminal structures after drug-eluting stent implantation. Cardiovascular Intervention and Therapeutics 29:1, pages 31-39.
Crossref
Crossref
Vivek Khanna, Manish Jain, Vishal Singh, Jitendra S. Kanshana, Prem Prakash, Manoj K. Barthwal, Puvvada S. R. Murthy & Madhu Dikshit. (2013) Cholesterol Diet Withdrawal Leads to an Initial Plaque Instability and Subsequent Regression of Accelerated Iliac Artery Atherosclerosis in Rabbits. PLoS ONE 8:10, pages e77037.
Crossref
Crossref
Flavio Ribichini, Michele Romano, Renato Rosiello, Luigi La Vecchia, Ester Cabianca, Giuseppe Caramanno, Diego Milazzo, Paolo Loschiavo, Stefano Rigattieri, Salvatore Musarò, Bruno Pironi, Antonio Fiscella, Francesco Amico, Ciro Indolfi, Carmen Spaccarotella, Antonio Bartorelli, Daniela Trabattoni, Francesco Della Rovere, Andrea Rolandi, Federico Beqaraj, Riccardo Belli, Pietro Sangiorgio, Rosvaldo Villani, Andrea Berni, Imad Sheiban, Maria Josè Lopera Quijada, Barbara Cappi, Licia Ribaldi & Corrado Vassanelli. (2013) A Clinical and Angiographic Study of the XIENCE V Everolimus-Eluting Coronary Stent System in the Treatment of Patients With Multivessel Coronary Artery Disease. JACC: Cardiovascular Interventions 6:10, pages 1012-1022.
Crossref
Crossref
Wahid Khan, Shady Farah, Abraham Nyska & Abraham J. Domb. (2013) Carrier free rapamycin loaded drug eluting stent: In vitro and in vivo evaluation. Journal of Controlled Release 168:1, pages 70-76.
Crossref
Crossref
Shady Farah, Wahid Khan & Abraham J. Domb. (2013) Crystalline coating of rapamycin onto a stent: Process development and characterization. International Journal of Pharmaceutics 445:1-2, pages 20-28.
Crossref
Crossref
Aristotelis C. Papayannis, Daisha Cipher, Subhash Banerjee & Emmanouil S. Brilakis. (2012) Optical coherence tomography evaluation of drug‐eluting stents. Catheterization and Cardiovascular Interventions 81:3, pages 481-487.
Crossref
Crossref
Yoon Hee Cho, Cheol Ryong Ku, Zhen-Yu Hong, Ji Hoe Heo, Eun Hee Kim, Dong Hoon Choi, Dongkyu Kim, Ae-Jung Kim, Cheol Soon Lee, Mankil Jung, Hyun Chul Lee, MiRan Seo & Eun Jig Lee. (2013) Therapeutic Effects of Water Soluble Danshen Extracts on Atherosclerosis. Evidence-Based Complementary and Alternative Medicine 2013, pages 1-11.
Crossref
Crossref
James M. Anderson & Frederick J. Schoen. 2013. Biomaterials Science. Biomaterials Science
609
617
.
Mounir WZ Basalus, Kenneth Tandjung, Hanim Sen, Aart A van Apeldoorn, Dirk W Grijpma & Clemens von Birgelen. (2012) Recent insights from scanning electron microscopic assessment of durable polymer-coated drug-eluting stents. Interventional Cardiology 4:6, pages 661-674.
Crossref
Crossref
Fumiyuki Otsuka, Masataka Nakano, Elena Ladich, Frank D. Kolodgie & Renu Virmani. (2012) Pathologic Etiologies of Late and Very Late Stent Thrombosis following First-Generation Drug-Eluting Stent Placement. Thrombosis 2012, pages 1-16.
Crossref
Crossref
Michail I. Papafaklis, Yiannis S. Chatzizisis, Katerina K. Naka, George D. Giannoglou & Lampros K. Michalis. (2012) Drug-eluting stent restenosis: Effect of drug type, release kinetics, hemodynamics and coating strategy. Pharmacology & Therapeutics 134:1, pages 43-53.
Crossref
Crossref
Takashi Sakakibara, Hideki Ishii, Takanobu Toriyama, Toru Aoyama, Hiroshi Takahashi, Daisuke Kamoi, Yoshihiro Kawamura, Kazuhiro Kawashima, Kohei Yoneda, Tetsuya Amano, Miho Tanaka, Daiji Yoshikawa, Mutsuharu Hayashi, Tatsuaki Matsubara & Toyoaki Murohara. (2012) Sirolimus-Eluting Stent vs. Everolimus-Eluting Stent for Coronary Intervention in Patients on Chronic Hemodialysis. Circulation Journal 76:2, pages 351-355.
Crossref
Crossref
Alexander Sheehy, Steven Hsu, Amelie Bouchard, Pablo Lema, Claudine Savard, Louis-Georges Guy, Julie Tai & Igor Polyakov. (2012) Comparative vascular responses three months after paclitaxel and everolimus-eluting stent implantation in streptozotocin-induced diabetic porcine coronary arteries. Cardiovascular Diabetology 11:1, pages 75.
Crossref
Crossref
J. Ribamar Costa Junior, Amanda G.M.R. Sousa, Adriana Costa Moreira, Ricardo A. da Costa, Galo Maldonado, Manuel N. Cano, Cantídio Campos Neto & J. Eduardo Sousa. (2012) Impact of Routine Use of Drug-eluting Stents in Contemporary Interventional Cardiology at a Tertiary Center: One-decade Experience of the DESIRE Registry. Revista Brasileira de Cardiologia Invasiva (English Edition) 20:4, pages 355-360.
Crossref
Crossref
James J. Kleinedler, Elysse A. Orchard, John D. Foley, Lynette K. Rogers, Valeria Y. Hebert & Tammy R. Dugas. (2011) A dietary approach to increase in-stent stenosis and face validity of a rat model for arterial angioplasty and stenting. Atherosclerosis 219:2, pages 484-491.
Crossref
Crossref
N. S. van Ditzhuijzen, M. van den Heuvel, O. Sorop, R. W. B. van Duin, I. Krabbendam–Peters, R. van Haeren, J. M. R. Ligthart, K. T. Witberg, D. J. Duncker, E. Regar, H. M. M. van Beusekom & W. J. van der Giessen. (2011) Invasive coronary imaging in animal models of atherosclerosis. Netherlands Heart Journal 19:10, pages 442-446.
Crossref
Crossref
Gaku Nakazawa. (2011) Stent thrombosis of drug eluting stent: Pathological perspective. Journal of Cardiology 58:2, pages 84-91.
Crossref
Crossref
Yoshihiro Yamamoto, Hajime Otani, Junji Iwasaka, Haengnam Park, Takao Sakuma, Hiroshi Kamihata & Toshiji Iwasaka. (2011) Comparison of neointimal morphology of in-stent restenosis with sirolimus-eluting stents versus bare metal stents: virtual histology-intravascular ultrasound analysis. Cardiovascular Intervention and Therapeutics 26:3, pages 186-192.
Crossref
Crossref
Vasim FarooqBill D. GogasPatrick W. Serruys. (2011) Restenosis. Circulation: Cardiovascular Interventions 4:2, pages 195-205.
Crossref
Crossref
Gaku Nakazawa, Aloke V. Finn, Marc Vorpahl, Elena R. Ladich, Frank D. Kolodgie & Renu Virmani. (2011) Coronary Responses and Differential Mechanisms of Late Stent Thrombosis Attributed to First-Generation Sirolimus- and Paclitaxel-Eluting Stents. Journal of the American College of Cardiology 57:4, pages 390-398.
Crossref
Crossref
José de Ribamar Costa Jr & Alexandre Abizaid. (2010) Novolimus™-eluting coronary stent system. Interventional Cardiology 2:5, pages 645-649.
Crossref
Crossref
Alexandre AbizaidJ. Ribamar CostaJrJr. (2010) New Drug-Eluting Stents. Circulation: Cardiovascular Interventions 3:4, pages 384-393.
Crossref
Crossref
Flavio Ribichini, Gerardo Ansalone, Antonio Bartorelli, Federico Beqaraj, Andrea Berni, Salvatore Colangelo, Maurizio D'Amico, Francesco Della Rovere, Antonio Fiscella, Gabriele Gabrielli, Ciro Indolfi, Luigi La Vecchia, Paolo Loschiavo, Giampietro Marinoni, Antonio Marzocchi, Diego Milazzo, Michele Romano, Pietro Sangiorgio, Imad Sheiban, Corrado Tamburino, Bernardino Tuccillo, Rosvaldo Villani, Barbara Cappi, Maria Josè Lopera Quijada & Corrado Vassanelli. (2010) A clinical and angiographic study of the XIENCE V everolimus-eluting coronary stent system in the treatment of patients with multivessel coronary artery disease. Study design and rationale of the EXECUTIVE trial. Journal of Cardiovascular Medicine 11:4, pages 299-309.
Crossref
Crossref
Akira Murata, David Wallace-Bradley, Armando Tellez, Carlos Alviar, Michael Aboodi, Alexander Sheehy, Leslie Coleman, Laura Perkins, Gaku Nakazawa, Gary Mintz, Greg L. Kaluza, Renu Virmani & Juan F. Granada. (2010) Accuracy of Optical Coherence Tomography in the Evaluation of Neointimal Coverage After Stent Implantation. JACC: Cardiovascular Imaging 3:1, pages 76-84.
Crossref
Crossref
Juan F. Granada, Carlos L. Alviar, David Wallace-Bradley, Matthew Osteen, Bijal Dave, Armando Tellez, Htut K. Win, Neal S. Kleiman, Greg L. Kaluza & Eli I. Lev. (2009) Patterns of activation and deposition of platelets exposed to the polymeric surface of the paclitaxel eluting stent. Journal of Thrombosis and Thrombolysis 29:1, pages 60-69.
Crossref
Crossref
Elena Ladich, Marc Vorpahl, Masataka Nakano & Renu Virmani. (2009) Latest on the pathology of drug-eluting stents. Interventional Cardiology 1:2, pages 165-174.
Crossref
Crossref
LAURA E. L. PERKINS, KATRIN H. BOEKE-PURKIS, QING WANG, STEVEN K. STRINGER & LESLIE A. COLEMAN. (2009) XIENCE V™ Everolimus-Eluting Coronary Stent System: A Preclinical Assessment. Journal of Interventional Cardiology 22, pages S28-S40.
Crossref
Crossref
Aloke V. Finn, Gaku Nakazawa, Frank D. Kolodgie & Renu Virmani. (2009) Temporal Course of Neointimal Formation After Drug-Eluting Stent Placement. JACC: Cardiovascular Interventions 2:4, pages 300-302.
Crossref
Crossref